Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Freytag
Premedication and Chemotherapy Agents Do Not Impair Imgatuzumab (GA201)-Mediated Antibody-Dependent Cellular Cytotoxicity and Combination Therapies Enhance Efficacy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport
Frontiers in Immunology
Allergy
Immunology
Correction To: Immunotherapy Utilizing the Combination of Natural Killer– And Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents With Poly (ADP-ribose) Polymerase (PARP) Inhibition
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Influenza a Virus Antibodies With Antibody-Dependent Cellular Cytotoxicity Function
Viruses
Virology
Infectious Diseases
Mast Cell Deficiency inKitW-shmice Does Not Impair Antibody-Mediated Arthritis
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Lapatinib Enhances Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity via Upregulation of HER2 in Malignant Mesothelioma Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Liver Diseases
Acta Hepatologica Japonica
Hepatology
Designing Immunity to HIV: Manipulating Antibody-Dependent Cellular Cytotoxicity Antibodies
HIV Therapy
A Novel Anti‑EGFR Monoclonal Antibody (EMab‑17) Exerts Antitumor Activity Against Oral Squamous Cell Carcinomas via Antibody‑dependent Cellular Cytotoxicity and Complement‑dependent Cytotoxicity
Oncology Letters
Cancer Research
Oncology
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
Frontiers in Immunology
Allergy
Immunology
